|  Nederlands |  English |
 
 

11/12/2002: Janssen Pharmaceutica invests another 50 million euros.

Beerse, 11 December 2002 - In a well-attended ceremony at which Annemie Neyts, Minister assigned to the Minister of Foreign Affairs, officiated, the Pharmaceutical Development building was officially opened at Janssen Pharmaceutica. In this new building, new drug formulations will be developed.
Harlan Weisman and
Mrs. Annemie Neyts
   
Modern medicines not only have to be efficacious and safe. They must also be able to be given in the right form according to the type of illness and the patient. A tablet can be made in such a way that it instantly dissolves in the mouth, or only after a quarter of an hour, when it has already passed through the stomach. The Pharmaceutical Development department has already developed its own technology to promote the solubility of medicines and their gradual release into the bloodstream. This technology increases therapeutic compliance, the efficacy of the treatment and reduces the risk of side-effects.
 

The new building has a surface area of almost 9,000 m2 and meets the strictest safety and environmental standards. In this way, the workers are fully protected against the active ingredients, and all solvents used are fully recuperated.
Fifty people work in the building.

 

The building will be used by a worldwide Center of Excellence within the Johnson & Johnson group, to which Janssen Pharmaceutica belongs. This means that every new medicine that is developed within Johnson & Johnson must first go through Beerse. A small production unit in the same building makes the necessary quantities of medicines for worldwide clinical trials.

The official opening ceremony was concluded with an extensive tour of the new department.

 
Dirk Collier, Ivo Van Assche, Mrs Annemie Neyts, Harlan Weisman and Peter Putteman.
 
Press Releases 2002
04/12/2002 Laboratory Technician Day on December 4, 2002 for the Kempen Catholic Technical College of Geel: an opportunity to become acquainted with Janssen Pharmaceutica in Beerse and… perhaps even the key to your future!
11/12/2002 Janssen Pharmaceutica invests another 50 million euros
08/10/2002 Scientists elect Johnson & Johnson as third most attractive employer in the world
20/09/2002 Janssen Pharmaceutica Goes for Public Transportation
10/09/2002 Durogesic reaches a milestone
01/09/2002 Risperdal Consta, a new generation of atypical antipsychotics
04/07/2002 2001 - A very successful year for Janssen Pharmaceutica
03/07/2002 Prime Minister Guy Verhofstadt lays the first stone of the new Discovery Research Center in Beerse
22/05/2002 "Beerse 2" is biggest computer- and telecomcenter for J&J-group in Europe
05/05/2002 Open house at Janssen Pharmaceutica in Geel a success!
18/04/2002 Data suggest Reminyl effectively treats dementia in patients with cerebrovascular disease
15/04/2002 Investing in research: patients are Worth the Risk
12/04/2002 J&J in top 50 Business week
04/04/2002 Janssen Pharmaceutica NV most engaging employer in Belgium
 

 

 
© Janssen Pharmaceutica N.V., 1997-2008.

This site is published by Janssen Pharmaceutica NV and is intended for visitors from Europe. Use of the site constitutes your consent to application of European laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to the terms of our Legal Notice.